4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000077
EVP, Chf Clinical Develop Ofcr sold 5,482 shares at $50.42 ($276,386)
- EVP, Chf Clinical Develop Ofcr acquired 15,162 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schneider Eugene · EVP, Chf Clinical Develop Ofcr
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 1 in the form | +15,162 | 53,332 | D | ||
| 2024-01-17 | Sale : show line 2 in the form | −5,482 | $50.42 | $276,386 | 47,850 | D |
| Open-market sales · 5,482 sh · avg $50.42 · $276,386 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −15,162 | $0.00 | 15,162 | 45,308 | D |
Loading xslF345X05/edgardoc.xml…